Non-Fungible Tokens for Organoids: Decentralized Biobanking to Empower Patients in Biospecimen Research

William Sanchez Orcid logo ,
William Sanchez
Larue Linder ,
Larue Linder
Robert Miller, ,
Robert Miller,
Amelia Hood ,
Amelia Hood
Marielle Gross Orcid logo
Marielle Gross

Published: 30.04.2024.

Biochemistry

Volume 7, Issue 1 (2024)

https://doi.org/10.30953/bhty.v7.303

Abstract

Introduction: Scientists use donated biospecimens to create organoids, miniature copies of patient tumors1 that are revolutionizing precision medicine2 and drug discovery. However, current biobanking platforms remove patient names to protect privacy, precluding communication of health information and research findings between bench and bedside3. We leverage tokenization, transparency, and privacy-preservation of blockchain technology to advance a decentralized biobanking prototype empowering patient engagement in organoid research. Methods: We design and develop a proof-of-concept NFT framework4 for a simulated human cancer model research network. Our implementation deployed multiple smart contracts on Ethereum test networks which minted NFTs representing each stakeholder, biospecimen, and organoid, a NodeJS server using a Metamask wallet to interact with blockchain through an Infura hosted node, and a Flutter mobile application connected to a Firebase Database to demonstrate biobanking activities. Results: Our prototype demonstrated the viability of NFTs representing patients, physicians, scientists, and organoids while preserving privacy, and displayed how decentralized biobanking could be integrated into existing biobanking platforms5. The application featured key activities for patients, including biospecimen tracking, the ability to view organoids, learn about ongoing studies, and peer-to-peer communications with scientists.  Discussion: Our prototype demonstrates proof-of-concept for a web3 platform that engages patients, physicians and scientists in an privacy-preserving organoid community. Further research is needed to advance decentralized biobanking features, encapsulating complex organoid research activities, and to assess feasibility and acceptability of implementing our approach.  

Keywords

References

1.
Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nature Cancer. 2022;3(2):232–50.
2.
Fda. Precision Medicine [Internet]. 2019;
3.
Gross MS, Hood AJ, Rubin JC, Miller RC. Respect, justice and learning are limited when patients are deidentified data subjects. Learning Health Systems. 2022;6(3).
4.
Gross M, Hood AJ, Sanchez WL. Blockchain Technology for Ethical Data Practices: Decentralized Biobanking Pilot Study. The American Journal of Bioethics. 2023;23(11):60–3.
5.
Charles W, Delgado B. Health datasets as assets: Blockchain-based valuation and transaction methods.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles